Pharmacokinetics of cefprozil in healthy subjects and patients with renal impairment.

Shyu, W C; Pittman, K A; Wilber, R B; Matzke, G R; Barbhaiya, R H

Shyu, W C; Pittman, K A; Wilber, R B; Matzke, G R; Barbhaiya, R H.

Affiliation

Shyu WC; Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Pharmaceutical Research Institute Syracuse, New York 13221-4755.

J Clin Pharmacol ; 31(4): 362-71, 1991 Apr.

Article in En | MEDLINE | ID: mdl-2037710

Subject(s)

Cephalosporins/pharmacokinetics; Kidney Failure, Chronic/metabolism; Administration, Oral; Adult; Cephalosporins/administration & dosage; Drug Evaluation; Female; Humans; Isomerism; Male; Metabolic Clearance Rate; Middle Aged; Renal Dialysis; Cefprozil

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Cephalosporins / Kidney Failure, Chronic Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Clin Pharmacol Year: 1991 Type: Article

Search on Google

XML

PubMed Links